| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| No holdings reported for quarter Q2 2014 | ||||||||
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| SUPERNUS PHARMACEUTICALS INC | 14 | Q1 2023 | 6.9% |
| NEW RELIC INC | 14 | Q1 2023 | 7.6% |
| 8X8 INC NEW | 14 | Q4 2023 | 7.4% |
| OPKO HEALTH INC | 13 | Q4 2023 | 3.0% |
| MANDIANT INC | 12 | Q1 2022 | 9.9% |
| INSIGHT ENTERPRISES INC | 12 | Q2 2024 | 7.2% |
| NUTANIX INC | 12 | Q4 2022 | 7.3% |
| ALTERYX INC | 11 | Q4 2023 | 4.6% |
| VEECO INSTRS INC DEL | 11 | Q2 2024 | 3.6% |
| MODEL N INC | 11 | Q4 2023 | 1.7% |
View Opti Capital Management, LP's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| N-PX | 2024-08-30 |
| 13F-HR | 2024-08-14 |
| 13F-HR | 2024-05-15 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
View Opti Capital Management, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.